Skip to main content
SupplementScience

UC-II (Undenatured Type II Collagen) — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

How is UC-II different from regular collagen supplements?

UC-II is undenatured (native) type II collagen that works through immune-mediated oral tolerance, not as a structural building block. Regular hydrolyzed collagen is broken down into amino acids and peptides for structural support at doses of 5-10g daily. UC-II works at just 40mg because its intact triple-helix structure interacts with the gut immune system to reduce autoimmune cartilage destruction.

Why must UC-II be taken on an empty stomach?

The oral tolerance mechanism requires the undenatured collagen structure to reach Peyer patches in the small intestine intact. Stomach acid and digestive enzymes activated by food can denature the collagen, destroying its native structure and eliminating the immune-modulatory effect. Taking it on an empty stomach with water minimizes this degradation.

Can I take UC-II together with glucosamine or chondroitin?

Yes. UC-II works through a completely different mechanism (immune modulation) than glucosamine and chondroitin (structural support). They are complementary rather than redundant. However, take UC-II separately on an empty stomach while glucosamine and chondroitin can be taken with meals.

References

  1. (). Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. Journal of the International Society of Sports Nutrition. DOI
  2. (). Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutrition Journal. DOI
  3. (). Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. International Journal of Medical Sciences. DOI